The advertisement promotes RINVOQ as a treatment for ulcerative colitis (UC), emphasizing its potential to achieve remission in as little as 8 weeks, while advising against temporary relief methods.
Creative Information
| CID: | e00ece1e-1a86-4d9f-82e0-ac74e981c460 |
| CRID: | 25_ce57dnuh |
| Domain: | abbvie.com |
| Seat: | TTD |
| Size: | 300x250 |
| Bid: | $2.60 |
| Timestamp: | 12/10/2025, 5:45:02 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/10/2025, 5:52:42 PM | 5.70s | |
| adomain_analysis | success | 12/10/2025, 6:00:44 PM | 5.04s | |
| adomain_capture | success | 12/10/2025, 6:00:39 PM | 0.22s | |
| ad_render | success | 12/10/2025, 5:52:36 PM | 32.32s | |
| brand_mapping | success | 12/10/2025, 5:45:03 PM | 0.11s | |
Analysis Results
Ad Format: banner
Brands: AbbVie
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1329.13 KB | ||||||||||||||||||||||
| Render Time: | 8.56 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1369.39 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


